Senior International Medical Digital Manager

Location: Ingelheim, Germany
Job Type: Full-Time
Employer: Boehringer Ingelheim
As Senior International Digital Medical Manager you will accelerate the adoption of digital within the specific Medical Therapeutic Area and live your passion of thinking outside of the box. You will be part of a dynamic team where you will have the opportunity to use your creative skills and digital mindset to provide a unique Boehringer Ingelheim customer experience.

Tasks & responsibilities

  • As Senior International Medical Digital Manager you create a plan to catalyse the medical digital transformation within the Therapeutic Area (TA) Oncology at Boehringer Ingelheim.
  • You will align with the Digital Manager and the Medical Affairs brand lead in order to ensure an optimal customer journey which is aligned with our brand and customer plans.
  • Furthermore, you will co-create the TA content to be innovative, cutting-edge and strategic as well as desirable and usable for the local country implementation, for example multi-channel content, videos, infographics and webinars.
  • In your new role you set key performance indicators to ensure measurability and the track user journey.
  • Last but not least you identify innovations that can evolve or transform the TA customer experience within the complex regulatory environment.

Requirements

  • Registered Medical Practitioner, Master of Science or PhD; experience in Therapeutic Areas/Oncology preferred
  • A minimum of 5 years of work experience regarding the following:
    • Significant medical experience within healthcare
    • Effective digital mindset to innovate, create the strategy and fully execute
    • Ability to implement new digital opportunities
    • Substantial experience in mix of local and international roles
    • Experience in a matrix organization and in cross-functional teams
  • Fluent English both written and spoken, German would be a plus

Apply for this job

About Boehringer Ingelheim
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry's top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.

Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects such as the "Making More Health" initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees' different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does.

Post your job offer now to start hiring the best eHealth talent! For further information, please contact us.

Most Popular Now

NHS and Patients to Benefit from New Par…

IMS MAXIMS and Secure Exchange Solutions have announced a partnership to offer mobile, secure and cost-effective provider-to-provider and provider-to-patient communications to NHS organisations, GP practices and patients.

Bayer is Taking Collaboration with Healt…

As a pioneer when it comes to collaborating with digital health start-ups, Bayer is now taking the next step. Instead of one-off startup programs, it is now focusing on collaborating...

International Master's in Digital Health

The Master of Science (M.Sc.) in Medical Informatics (MMI) at European Campus Rottal-Inn (ECRI) in Pfarrkirchen - a branch of the Deggendorf University of Applied Sciences (THD - Technische Hochschule...

New Antibiotics Are Desperately Needed: …

As the threat of antibiotic resistance looms, microbiologists aren’t the only ones thinking up new solutions. James Zou, PhD, assistant professor of biomedical data science at Stanford, has applied machine...

Digital Medicine: The Opportunities and …

9 - 11 April 2019, Berlin, Germany. Be it preventive healthcare for dementia using intuitive apps, anonymous hospital hygiene inspections using IoT sensors, or VR applications that let hemiplegic patients live...

Highland Marketing Forms Alliance with E…

An alliance between Highland Marketing and Experiential HealthTech will be announced at this year's Digital Health Rewired, with both companies exhibiting from stand B14. Highland Marketing is a full-service marketing...

Google Research Shows How AI can Make Op…

As artificial intelligence continues to evolve, diagnosing disease faster and potentially with greater accuracy than physicians, some have suggested that technology may soon replace tasks that physicians currently perform. But...

Virtual Reality could be Used to Treat A…

Playing games in virtual reality (VR) could be a key tool in treating people with neurological disorders such as autism, schizophrenia and Parkinson's disease. The technology, according to a recent...

Open Call SC1-HCC-02-2019: Support for t…

In the past years several open service platforms for Active and Healthy Ageing domains have been developed, originating from the medical, independent living, and IoT domain. These platforms aim at...

The Moore Blatch Silicon Cup Opens for E…

This year's Moore Blatch Silicon Cup has been launched and is now open for IT companies to enter. The event takes place over 26 - 27 September on the Isle...

MEDICA 2019: Clear Focus on Future Topic…

18 - 21 November 2019, Düsseldorf, Germany. As a result of the final phase of exhibitor registrations for the world’s leading medical trade fare MEDICA 2019 in Düsseldorf, one thing is...